Qube Research & Technologies Ltd - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 174 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$22,663
-94.6%
58,260
-93.8%
0.00%
-100.0%
Q2 2023$421,581
+30.4%
944,190
+139.5%
0.00%
+100.0%
Q1 2023$323,301
+94.8%
394,270
+310.1%
0.00%0.0%
Q3 2022$166,000
-53.6%
96,137
-53.5%
0.00%
-66.7%
Q2 2022$358,000
+302.2%
206,767
+735.8%
0.00%
+200.0%
Q1 2022$89,000
-79.5%
24,738
-71.6%
0.00%
-66.7%
Q4 2021$434,000
+1176.5%
86,996
+753.1%
0.00%
+200.0%
Q4 2019$34,00010,1980.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Sante Capital Fund, LP 115,637$1,072,0000.44%
Defender Capital, LLC. 135,466$1,255,0000.42%
Green Alpha Advisors, LLC 62,566$580,0000.40%
Harvest Investment Services, LLC 51,239$474,0000.20%
SEVEN EIGHT CAPITAL, LP 118,270$1,096,0000.15%
Cedar Brook Financial Partners, LLC 54,500$505,0000.15%
WASATCH ADVISORS LP 3,576,706$33,156,0000.14%
Banco BTG Pactual S.A. 20,000$185,0000.12%
Keystone Financial Group 60,712$563,0000.10%
Virtus ETF Advisers LLC 25,105$233,0000.10%
View complete list of INOVIO PHARMACEUTICALS INC shareholders